Cargando…
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
The protozoan parasite Cryptosporidium is a leading cause of diarrheal disease (cryptosporidiosis) and death in young children. Cryptosporidiosis can be life-threatening in individuals with weak immunity such as HIV/AIDS patients and organ transplant recipients. There is currently no effective drug...
Autores principales: | Nava, Maria G., Calderón, Félix, Fernández, Elena, Ballell, Lluis, Bamborough, Paul, Vinayak, Sumiti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927415/ https://www.ncbi.nlm.nih.gov/pubmed/36533912 http://dx.doi.org/10.1128/spectrum.03874-22 |
Ejemplares similares
-
A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum
por: Choudhary, Hadi H., et al.
Publicado: (2020) -
Genetic modification of the diarrheal pathogen Cryptosporidium parvum
por: Vinayak, Sumiti, et al.
Publicado: (2015) -
Crystal Structure of Cryptosporidium parvum Pyruvate Kinase
por: Cook, William J., et al.
Publicado: (2012) -
Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy
por: Khan, Shahbaz M., et al.
Publicado: (2022) -
Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth In Vitro
por: Funkhouser-Jones, Lisa J., et al.
Publicado: (2020)